Developmental Pathophysiology, Devel. Physiol., Dr. D. Penney


Whole Lecture Index - Module 23

Introduction - Toxipharmacologic Risks (Page 1)

Toxipharmacologic Risks - Birth Defects (Page 2)

Toxipharmacologic Risks - Examples (Page 3)

Toxipharmacologic Risks - More Examples (Page 4)

Congenital CV Defects - Introduction (Page 5)

Classes of Congenital CV Defects (Page 6)

Shunting (Page 7)

Use of dyes in detecting shunts (Page 8)

Cyanosis (Page 9)

Murmurs (Page 10)


"Leakiness" and Murmurs (Page 11)

Frequency of Congenital CV Defects (Page 12)

Atrial Septal Defects (Page 13)

More on ASDs (Page 14)

Ventricular Septal Defects (Page 15)

More on VSDs (Page 16)

Pulmonary Vascular Disease (Page 17)

Pulmonary Hypertension (Page 18)

Calculation of Shunt Flow (Page 19)

Pulmonary Stenosis (Page 20)


Tetralogy of Fallot (Page 21)

Transposition of Great Vessels (Page 22)

Coarctation of the Aorta (Page 23)

Other Congenital Defects (Page 24)

Neonatal Hyperviscosity Syndrome (Page 25)

Etiology of Neonatal Hyperviscosity Syndrome (Page 26)

Blood Volume at Birth (Page 27)

Placental-Fetal Pathologies (Page 28)

Neonatal Heart Failure (Page 29)

Mechanism(s) of Neonatal HF (Page 30)


The Hemoglobin Changeover and Neonatal HF (Page 31)

Treatment for Neonatal HF (Page 32)


Right above: Human embryos, 5 and 6 months of age.



Return to Main Index